SCHEMBL5012991

SCHEMBL5012991

Cc1cc(Cl)c(Cl)cc1S(N)(=O)=O

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 13/20 0.49
CA2 P00918 13/20 0.49
CA9 Q16790 11/20 0.49
CA12 O43570 10/20 0.49
CA4 P22748 5/20 0.47
CA6 P23280 4/20 0.47
CA5A P35218 4/20 0.47
CA7 P43166 4/20 0.47
CA14 Q9ULX7 4/20 0.47
CA5B Q9Y2D0 4/20 0.47
CA3 P07451 3/20 0.47
CA13 Q8N1Q1 3/20 0.45
LMNA P02545 2/20 0.45
CYP2C9 P11712 2/20 0.45
POLB P06746 1/20 0.45
APEX1 P27695 1/20 0.45
TDP1 Q9NUW8 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.45
KDM4E B2RXH2 1/20 0.45
ALDH1A1 P00352 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6038490 0.89 CA2 (0.56) CA1CA2CA9CA12CA4
Disulfamide SCHEMBL309326 0.89 CA1 (0.61) CA1CA2CA9CA12CA4
SCHEMBL8404547 0.85 CA1 (0.42) CA1CA2CA9CA12CA4
SCHEMBL11554246 0.84 CA1 (0.50) CA1CA2CA9CA12CA4
SCHEMBL3500908 0.83 CA1 (0.56) CA1CA2CA9CA12CA4
SCHEMBL11552574 0.82 CA1 (0.48) CA1CA2CA9CA12CA4
SCHEMBL11511279 0.80 KDM4E (0.52) CA1CA2CA9CA12CA4
SCHEMBL26512818 0.79 TRPV4 (0.38) CA1CA2CA9CA12L3MBTL1
SCHEMBL6038485 0.78 CA1 (0.64) CA1CA2CA9CA12CA4
SCHEMBL28827972 0.78 ALDH1A1 (0.50) CA1CA2CA9CA12CA4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008093919-A1 USE OF N-BENZYL-N-(2-DIMETHYLAMINO-ETHYL)BENZENESULFONAMIDE DERIVATIVES FOR TREATING CENTRAL NERVOUS SYSTEM DISORDERS DONGBU HITEK CO., LTD. (KR) 2008-08-07 WO claimed